Umban, Venerando S.

HRN: 26-27-38  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/05/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/05/2025
07/11/2025
IV
2.25g
Q8h
Complicated UTI
Checking Initial Appropriateness 

 Indication:  Empirical Escalation    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines